International Human Capacity Development (IHCD)

Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)

Code : 9345-353632 Publish Date : Monday, November 20, 2017 Visit : 1538

Intl. Congress form | International Congress Report | International Congress Report For Faculty | The report of 18th Congress of the International Headache Society by Dr. Mansoureh Togha

The report of 18th Congress of the International Headache Society by Dr. Mansoureh Togha

Application Code :

762-0217-0089

Created Date : Saturday, October 14, 2017-13:00 13:00:57Update Date : Wednesday, November 15, 2017-12:03 12:03:36
IP Address : 194.225.214.18Submit Date : Wednesday, November 15, 2017-12:57 12:57:36Email :toghae@sina.tums.ac.ir

Personal Information

Name :	mansoureh
Surname :	togha
School/Research center :	School of Medicine
If you choose other, please name your Research center :	Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
Position :	Professor
Mobile :	+21-631-2506

Information of Congress

Title of the Congress :	18th Congress of the International Headache Society
Title of your Abstract :	Prevalence of Migraine in Patients with Idiopathic Intracranial Hypertension (IIH) in Comparison to the general population
Destination Country :	Canada
From :	Thursday, September 7, 2017
To :	Sunday, September 10, 2017
Abstract(Please copy/paste the abstract send to the congress) :	Objectives: Idiopathic intracranial hypertension (IIH) is a neurological disorder that is characterized by increased intracranial pressure (ICP) accompanied by a small or normal sized ventricles of the brain. The main presenting symptom of IIH is headache that usually is severe. IIH may lead to visual and hearing impairment or even loss of vision. The initial treatment would be medical and conservative. However, some patients may even need surgical intervention to divert CSF flow to decrease the intracranial pressure. On the other hand it seems that migraine headache is common among IIH patients and sometimes it is misdiagnosed as the headache of IIH and might lead to inappropriate management. In the present study, the prevalence of migraine in IIH patients is explored in comparison with the normal population. Methods: In this case-control study, the presence of migraine in 108 IIH patients was evaluated in comparison to 103 non-IIH subjects. The diagnosis of IIH and migraine was done according to the diagnosis criteria of high opening CSF pressure (>25–40cmH2O) and (ICHD III beta) criteria. In order to collect the required information, all subjects were interviewed by a trained medical student. A checklist for migraine diagnosis was filed. Demographic data was collected. IIH patient’ medical documents were explored and variables such as age, BMI (Body Mass Index), Cerebro-Spinal Fluid pressure, presence or absence of Papilledema were studied. Data analysis was done using Stata software, Version 11. Results: 211 subjects (86.7% female) with mean age of 38.0412.19 and mean BMI of 28.124.93 kg/m2 were studied. In the IIH patients 93 cases (81.6%) had papilledema and the mean CSF pressure was 32.10 cm H2O (Range: 26 cm H2O to 65 cm H2O). There were 70 (64.8%) and 22 (21.4%) migraine patients in case and control groups respectively which the difference was found significant (P-value<0.001). In 26 of 70 (24.1%) migraine cases in IIH group the disorder was diagnosed after developing IIH. The risk of affecting by migraine in IIH patients was 6.17 times greater than the non-IIH group (95%CI¼3.56–14.36 p<0.01). Conclusion: According to the higher probability of migraine and even the possibility of developing new onset migraine in IIH patients, taking precise headache history in the follow up period is necessary. This consideration prevents misdiagnosis of migraine headache as the recurrence of IIH or uncontrolled IIH and its inappropriate management. Disclosure of Interest: None Declared
Keywords of your Abstract :	Migraine, Idiopathic Intracranial Hypertension (IIH), CSF pressure
Acceptance Letter :	http://gsia.tums.ac.ir/images/UserFiles/21636/Forms/762/Gmail_-_Abstract_submission_for_the_18th_Congress_of_the_International_Headache_Society-1__1_.pdf
The presentation :	Poster
The Cover of Abstract book :	http://gsia.tums.ac.ir/images/UserFiles/21636/Forms/762/3118_ihc-2017-abstracts-first.pdf
Published abstract in the abstract book with the related code :	http://gsia.tums.ac.ir/images/UserFiles/21636/Forms/762/Prof Togha abs_1.pdf
Where has your abstract been indexed? :	ISI
If you choose other, please name :

The Congress Reporting Form

How many volunteers were present at the Congress? :	There was about 3000 participants.
Delegates from which countries presented in the congress? :	Denmark, USA, Germany, Sweden, Italy, Brszil
Were the delegates of any other organizations present in the congress? :	Yes
If yes, please write the names of the organizations in the box :	American Headache Society, Danish Headache Society, German Headache Society
What were the responses to your talking points? Were specific questions or concerns raised? :
If you met staff members, please list their full names & positions. :	Prof. Jes Olesen, Prof. Stephan Evers, Prof. Allan Purdy, Prof Alan Rapoport, Prof. Rigmor Jensen, Dr. Astrid Gendolla,
Please inform us if there are any follow up actions we need to talk with the members of the congress :
Your experiences about the travel processes(Providing ticket, accommodation,...) :	Te procedure for getting VISA was very complicated and time consuming. I got my VISA in the last minutes so I had to change my ticket 3 times. The Iranian participants of this unique event of headache field were limited so it was so important for me to attend the congress as an Iranian representative and Iranian headache association president.
Please give a briefing of your own observations and outcomes of the congress: :	The scientific programme ran from Thursday 7 September to Sunday 10 September with advanced educational Teaching Courses, and some Lectures on basic science in headaches including migraine pathophysiology specially in cluster headache in addition to a session on the new Classification of headaches. There was also some interesting presentations on the vulnerability to migraine, the paradox of medication overuse headache and trigeminal neuralgia, biomarkers of migraine, new drugs and therapeutic approaches in different types of headache and migraine. the most discussed topics on migraine new treatments were CGRP antibodies and CGRP receptor antagonists. Regarding non-pharmacological treatments of migraine, neuromodulation techniques was introduced. Also, the poster walks were complemented by all participants for their interactive communications. In addition, a separate session was dedicated to young researchers lectures.